Skip to main content

DuPont Licenses DxS Multiplex Assay Technology

NEW YORK (GenomeWeb News) — DuPont's Qualicon business has licensed DxS' Scorpion multiplex assay platform for use in developing diagnostic tests for the food industry.

Under the agreement, DuPont Qualicon will use the Scorpions technology, a closed-tube platform for PCR analysis for which Manchester, UK-based DxS owns the worldwide intellectual property rights, for use in its development of rapid multiplex assays for detecting microorganisms in food as well as beverage safety and quality.

Financial terms of the agreement were not released.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.